Year in Review 2024 - Ovarian Cancer

Oncology 2024 Year in Review

E. Crane

Recent FDA Indications in Endometrial Cancers

Brian Slomovitz

ASCO® 2024 Insights: "The ABCs of ADCs - What Does the Future Hold?"

2024 ASCO® Annual Meeting Insights Hub

E. Hamilton

ESMO 2024 Insights: Final OS With Niraparib as 1L Maintenance in Adv…

2024 ESMO Annual Meeting Insights Hub

B. Monk

IGCS 2024 Summary and Highlights: Key Trial Insights on Endometrial …

UCLA Health

D. Chase

Endometrial Cancer: Risk Factors, Prognostic Challenges, and Staging…

Hope Cottrill

Year in Review 2024 - Endometrial Cancer

Mansoor Raza Mirza

SOCCER-P Trial: Secondary Cytoreductive Surgery in Relapsed Ovarian …

Hyun-Woong Cho

Gynecologic Oncology Updates: Expert Perspective on Key Trial Findin…

Yale Cancer Center

E. Ratner

ESMO 2024 Summary: dMMR Advanced/Recurrent Endometrial Cancer - Adva…

2024 ESMO Annual Meeting Insights Hub

M. Raza Mirza

Comprehensive Review of PARP Inhibitors in Ovarian Cancer: Role of O…

Alexander Olawaiye

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

The Changing Field of Endometrial Cancer Treatment

GRACE

M. Raza Mirza

ASCO® 2024 Summary: "Gynecological Cancers Highlights"

2024 ASCO® Annual Meeting Insights Hub

M. Raza Mirza

Rad Onc 101: Radiation Oncology Basics

Nina Niu Sanford

N. Sanford

Early Detection and Risk Prediction in Ovarian Cancer: The Role of m…

Ovarian Cancer Midwest Focus, University of Minnesota

K. Elias

Endometrial Cancer: The Current Treatment Landscape

Hope Cottrill

OVATION 2 Trial: IMNN-001 Immunotherapy + Chemo for Advanced Ovarian…

Premal Thaker

Comprehensive Review and Treatment Updates in Endometrial Cancer

University of Illinois Cancer Center

J. Ray

Year in Review 2024 - The Role of Medical Treatment in Cervical Canc…

Oncology 2024 Year in Review

D. Lorusso